Acid Reducer (Ranitidine) Tablet: N-nitrosodimethylamine (NDMA) impurity
Summary
See instructions below.
Affected products
Brand / |
Product Name / |
Market Authorization / |
Dosage Form / |
Strength / |
Lot number / |
|---|---|---|---|---|---|
Atoma |
ATOMA-ACID RED MAX F 150mg C ALV 3X8 |
DIN 02293471 |
Tablet / Comprimé |
Ranitidine 150 mg |
627765H |
Option+ |
OPTION+ REDUC ACIDE 75mg COMP ALV 1x10 |
DIN 02247551 |
Tablet / Comprimé |
Ranitidine 75 mg |
632952B |
Option+ |
OPTION+ REDUC ACIDE 75mg COMP ALV 4X10 |
DIN 02247551 |
Tablet / Comprimé |
Ranitidine 75 mg |
633694B |
Option+ |
Option+ REDUC ACID F MAX 150mg CO ALV3X8 |
DIN 02293471 |
Tablet / Comprimé |
Ranitidine 150 mg |
627765G |
Option+ |
Option+ REDUC ACID F MAX 150mg CO AL 1X8 |
DIN 02293471 |
Tablet / Comprimé |
Ranitidine 150 mg |
627765B |
Rexall Corp |
Rexall Corp-REDUC ACIDE 150mg CO ALV 3X8 |
DIN 02293471 |
Tablet / Comprimé |
Ranitidine 150 mg |
627765F |
Rexall Corp |
Rexall Corp-REDUC ACIDE 150mg CO ALV 1X8 |
DIN 02293471 |
Tablet / Comprimé |
Ranitidine 150 mg |
627765A |
Biomedic |
BIOMEDIC REDUC ACIDE 75mg COMP ALV 3X10 |
DIN 02247551 |
Tablet / Comprimé |
Ranitidine 75 mg |
632952I |
Biomedic |
BIOMEDIC-ACID RED F MAX 150mg COM ALV3X8 |
DIN 02293471 |
Tablet / Comprimé |
Ranitidine 150 mg |
627765I |
Biomedic |
BIOMEDIC-ACID RED F MAX 150mg COM ALV3X8 |
DIN 02293471 |
Tablet / Comprimé |
Ranitidine 150 mg |
628471C |
LD |
LD-REDUC ACIDE F MAX 150mg COMP ALV 3X8 |
DIN 02293471 |
Tablet / Comprimé |
Ranitidine 150 mg |
627765E |
Pharmasave |
PHARMASAVE-RED ACID F MAX 150mg CO AL1X8 |
DIN 02293471 |
Tablet / Comprimé |
Ranitidine 150 mg |
627765C |
Pharmasave |
PHARMASAVE-RED ACID F MAX 150mg C ALV3X8 |
DIN 02293471 |
Tablet / Comprimé |
Ranitidine 150 mg |
628471B |
Co-op Care + |
CO-OP CARE + ACID REDU F M 150mg C AL3X8 |
DIN 02293471 |
Tablet / Comprimé |
Ranitidine 150 mg |
627765D |
Compliments |
Compliments-REDUC ACIDE 150mg C ALV 3X8 |
DIN 02293471 |
Tablet / Comprimé |
Ranitidine 150 mg |
628471D |
Health One |
Health One-REDUC ACIDE 150mg COM ALV 4X8 |
DIN 02293471 |
Tablet / Comprimé |
Ranitidine 150 mg |
628471A |
Personnelle |
Personnelle-REDUC ACIDE 75mg CO ALV1X10 |
DIN 02247551 |
Tablet / Comprimé |
Ranitidine 75 mg |
632952D |
LB |
LB-REDUC D'ACIDE 75mg COMP ALV 3X10 |
DIN 02247551 |
Tablet / Comprimé |
Ranitidine 75 mg |
632952K |
Issue
Presence of N-nitrosodimethylamine (NDMA) above the acceptable concentration limit in affected lots.
What you should do
- Verify if your product is affected.
- Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
- Contact the recalling firm if you have any questions about the recall.
- Report any health product related side effects to Health Canada.
- Report any other health product safety complaints to Health Canada.
Related recalls and alerts
Additional information
Background
Depth of recall: Retailers
Details
|
Pharmasience Inc. Suite 100, 6111, Royalmount Avenue, Montreal, Quebec H4P 2T4 |
Get notified
Receive notifications for new and updated recalls and alerts by category.